Ethiopian ophthalmology benefits from Croma donation

Article

In a recent news release, Croma has described its support to Light for the World.

In a recent news release, Croma has described its support to Light for the World.

For over 10 years, the company has donated intraocular lenses (IOLs) and viscoelastic fluids that have also been used in Burkina Faso, DR Kongo, Mozambique, Pakistan and Uganda during 2010. Additionally, a large part of the year's in-kind support has benefitted the Department of Ophthalmology at the University in Jimma, Western Ethiopia.

A shortage of ophthalmologists and eye nurses in Ethiopia means that simple cataract surgery cannot be performed. Jimma university is just one of two institutions that trains ophthalmologists and provides a sustainable health service.

Andreas Prinz, managing director of Croma, commented: "We live up to ethical principles. By supporting Light for the World, we are supporting blind people in developing countries who are less fortunate."

Recent Videos
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Christiana Dinah speaks about her ASRS presentation, Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Chase Ludwig, MD, shared an overview of his presentation, which covered real-impact of vitrectomy surgery on the progression of AMD at the annual ASRS meeting in Stockholm, Sweden
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.